Please login to the form below

Shingrix

This page shows the latest Shingrix news and features for those working in and with pharma, biotech and healthcare.

The company achieved three major approvals last year - shingles vaccine Shingrix, respiratory treatment Trelegy Ellipta and HIV combination Juluca.

The year of the blockbuster

In the EU, the EMA granted accelerated assessment. Shingrix (Zoster vaccine recombinant, adjuvanted) from GlaxoSmithKline:Shingrix was approved in the US in October 2017 and was launched nationwide in March 2018, ... Shingrix is projected to become the
GSK’s vaccines president Debruyne heads for the exit

His responsibilities stretched to preparing the launch of Shingrix, GSK’s tipped blockbuster-in-waiting shingles vaccine, which pulled in sales of £110m ($150m) for the company in the first quarter
GSK gets maintenance indication for Trelegy

Among GSK’s other critical growth products shingles vaccine Shingrix made £110m in the first quarter - stronger than expected - while its HIV portfolio grew 6% to £1.05bn, which some analysts
Gilead’s triple HIV drug approval prompts GSK lawsuit

vaccine Shingrix and recently-approved triple therapy for chronic obstructive pulmonary disorder (COPD) Trelegy - as it faces the imminent threat of generic competition to its big-selling respiratory drug Advair (salmeterol ... Shingrix was approved in
GSK’s ViiV gets US okay for two-drug HIV regimen

It’s an important drug for GSK, and along with shingles vaccine Shingrix and recently-approved triple therapy for chronic obstructive pulmonary disorder (COPD) Trelegy.

More from news
Approximately 8 fully matching, plus 14 partially matching documents found.

Deal Watch January 2018

In October 2017 GSK's QS-21 Stimulon herpes zoster vaccine, Shingrix, was approved by the FDA.

More from intelligence
Approximately 0 fully matching, plus 1 partially matching documents found.

Account Director - Award Winning Healthcare Advertising Agency -...: £50000 - £68000

Senior Medical Writer, MedComms Agency: £40 - 55, 000 according to skills and experience benefits

Scientific Director – Medical Communications - New York or Remot...: $100000 - $150000

Science Writer, Healthcare Advertising Agency: £40, 000 - 45, 000 DOE benefits,

Senior/ Market Access Consultant, UK, HOME BASED, £50-60K: Excellent package

Account Director, Medical Communications & Events: £50 - 65, 000 according to skills and experience benefits

Principal Medical Writer / Editorial Director – Medical Communic...: £60, 000 - £80, 000

Senior Medical Writer, Principal Medical Writer, Scientific Dire...: £40000 - £75000 Bonus Benefits

Senior Account Manager / Account Director - Medical Education – ...: Salary TBC

Add my company

Cello Health Insight is the global market research arm of Cello Health. With 35 years’ sector experience, we specialise in...

The gene therapy revolution: Gene therapies are bringing new hope for many people with diseases caused by genetic disorders...
PM Society Digital Awards – the power of together: Our chief executive, Emma Statham, writes about the value of awards and the power of together....
Seduce anyone in four simple steps: You know the health of the global economy is dependent on our ability to seduce one another – don’t you? And you know that we need to be able to...